Savvy's functional beverage targets stress, menopause in Australia's expanding market
Australian brand Savvy has launched 'Calm Water', a functional beverage combining high-dose L-theanine and magnesium, targeting stress reduction and menopausal support without sedation. This product aims to capture market share in the underserved functional relaxation category.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Sydney, Australia — 16 April 2026
Savvy, an Australian brand, has released 'Calm Water', a ready-to-drink functional beverage positioned to alleviate stress, reduce anxiety, and support mental performance, while also addressing menopausal symptoms. This product, initially soft-launched in December 2025 and commercially available from February 2026 via Savvy's website and select Australian retailers, claims to be the first of its kind in the Australian market.
The formulation incorporates high-dose L-theanine, magnesium, schisandra berry extract, prebiotics, and B and C vitamins. Founder Mark Curry asserts that 'Calm Water' utilises significantly higher levels of active ingredients—reportedly over 10 times those found in typical functional beverages or powdered alternatives—to avoid merely 'label appeal' and deliver genuine efficacy. The product's design focuses on mitigating neurological overstimulation, regulating cortisol, and easing physical tension without inducing sedation, thereby allowing continued productivity.
A critical focus area for 'Calm Water' is support for women experiencing perimenopause and menopause. Curry highlights that hormonal fluctuations during these stages often lead to elevated cortisol levels, increased emotional sensitivity, and disrupted sleep. The beverage aims to regulate these erratic cortisol levels, addressing common symptoms such as hot flushes, mood swings, and sleep disturbances, which can compromise daily function and mental clarity. This strategic targeting taps into a growing and often underserved consumer segment.
Curry identifies a significant gap in the 'functional relaxation' category for products that provide stress relief without cognitive impairment. He noted that many existing calming agents, including traditional herbal teas with ingredients like valerian root or passion flower, are sedatives. 'Calm Water' differentiates itself by aiming to upregulate gamma-aminobutyric acid (GABA) and elevate alpha brain waves, promoting relaxation while maintaining mental alertness. This approach challenges common consumer perceptions about stress-reducing supplements, which often associate calmness with sleepiness. Furthermore, Savvy seeks to raise consumer awareness regarding the role of nutrition in mental health, a concept Curry believes is not fully understood by the broader public.
What this means for Australia
Australian supplement manufacturers and brand owners face increased competition in the functional beverage space, particularly with Savvy setting a precedent for high-dose active ingredients. Companies must assess their current product formulations and consider reformulation windows to meet evolving consumer expectations for efficacy and Ingredient transparency. The explicit targeting of perimenopausal and menopausal women presents a commercial opportunity; brands should evaluate market entry or expansion into this specific demographic with science-backed, non-sedating solutions. Procurement leads must secure reliable supply chains for ingredients like L-theanine and magnesium to support higher dosage demands. Regulatory teams should monitor competitor claims regarding dosage and efficacy, ensuring all product messaging remains compliant with TGA guidelines, especially concerning specific health targets like cortisol regulation and menopausal support.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.